{"id":162,"date":"2026-11-12T07:05:07","date_gmt":"2026-11-12T07:05:07","guid":{"rendered":"https:\/\/genetec.io\/?p=162"},"modified":"2026-11-12T07:05:07","modified_gmt":"2026-11-12T07:05:07","slug":"peptide-testing-daily-12-november-2026","status":"publish","type":"post","link":"https:\/\/genetec.io\/?p=162","title":{"rendered":"Peptide Testing Daily: 12 November 2026"},"content":{"rendered":"\r\n

New public test results since the last issue. Source: Finnrick’s public data summary<\/a>, latest test 10 Nov 2026. Results are information, not endorsements or medical advice.<\/em><\/p>\r\n\r\n\r\n\r\n

The headline<\/h2>\r\n\r\n\r\n\r\n

61 new tests<\/strong> across 31 peptides. Running total: 12,791 tests on 42 peptides, 70% passing<\/strong> Finnrick’s default standard.<\/p>\r\n\r\n\r\n\r\n

New results by peptide<\/h2>\r\n\r\n\r\n\r\n
\r\n
Peptide<\/th>New tests<\/th>Passed<\/th>Failed<\/th>All tests<\/th>Overall pass rate<\/th><\/tr><\/thead>
Retatrutide<\/a><\/td>8<\/td>2<\/td>0<\/td>4,717<\/td>77%<\/td><\/tr>\r\n
Tirzepatide<\/a><\/td>6<\/td>4<\/td>-1<\/td>2,868<\/td>78%<\/td><\/tr>\r\n
GHK-Cu<\/a><\/td>5<\/td>4<\/td>0<\/td>1,011<\/td>85%<\/td><\/tr>\r\n
Semaglutide<\/a><\/td>5<\/td>2<\/td>0<\/td>386<\/td>67%<\/td><\/tr>\r\n
Tesamorelin<\/a><\/td>3<\/td>0<\/td>0<\/td>756<\/td>48%<\/td><\/tr>\r\n
MOTS-c<\/a><\/td>3<\/td>0<\/td>0<\/td>91<\/td>35%<\/td><\/tr>\r\n
SS-31<\/a><\/td>3<\/td>0<\/td>0<\/td>26<\/td>too few<\/td><\/tr>\r\n
BPC-157<\/a><\/td>2<\/td>0<\/td>0<\/td>945<\/td>50%<\/td><\/tr>\r\n
Sermorelin<\/a><\/td>2<\/td>0<\/td>0<\/td>51<\/td>too few<\/td><\/tr>\r\n
5-Amino-1MQ<\/a><\/td>2<\/td>0<\/td>0<\/td>18<\/td>too few<\/td><\/tr>\r\n
Epithalon<\/a><\/td>2<\/td>0<\/td>0<\/td>10<\/td>too few<\/td><\/tr>\r\n
Ipamorelin<\/a><\/td>1<\/td>0<\/td>0<\/td>459<\/td>67%<\/td><\/tr>\r\n
CJC-1295<\/a><\/td>1<\/td>0<\/td>0<\/td>339<\/td>29%<\/td><\/tr>\r\n
TB-500<\/a><\/td>1<\/td>0<\/td>0<\/td>296<\/td>39%<\/td><\/tr>\r\n
Cagrilintide<\/a><\/td>1<\/td>0<\/td>0<\/td>208<\/td>54%<\/td><\/tr>\r\n
Melanotan II<\/a><\/td>1<\/td>0<\/td>0<\/td>184<\/td>62%<\/td><\/tr>\r\n
PT-141<\/a><\/td>1<\/td>0<\/td>0<\/td>158<\/td>65%<\/td><\/tr>\r\n
hCG<\/a><\/td>1<\/td>0<\/td>0<\/td>12<\/td>too few<\/td><\/tr>\r\n
Glutathione<\/a><\/td>1<\/td>0<\/td>0<\/td>9<\/td>too few<\/td><\/tr>\r\n
Semax<\/a><\/td>1<\/td>0<\/td>0<\/td>6<\/td>too few<\/td><\/tr>\r\n
DSIP<\/a><\/td>1<\/td>0<\/td>0<\/td>5<\/td>too few<\/td><\/tr>\r\n
Kisspeptin<\/a><\/td>1<\/td>0<\/td>0<\/td>4<\/td>too few<\/td><\/tr>\r\n
AOD-9604<\/a><\/td>1<\/td>0<\/td>0<\/td>2<\/td>too few<\/td><\/tr>\r\n
Selank<\/a><\/td>1<\/td>0<\/td>0<\/td>2<\/td>too few<\/td><\/tr>\r\n
ARA-290<\/a><\/td>1<\/td>0<\/td>0<\/td>1<\/td>too few<\/td><\/tr>\r\n
BPC-TB-Cartalax<\/a><\/td>1<\/td>0<\/td>0<\/td>1<\/td>too few<\/td><\/tr>\r\n
K-Copper<\/a><\/td>1<\/td>0<\/td>0<\/td>1<\/td>too few<\/td><\/tr>\r\n
LL-37<\/a><\/td>1<\/td>0<\/td>0<\/td>1<\/td>too few<\/td><\/tr>\r\n
SNAP-8<\/a><\/td>1<\/td>0<\/td>0<\/td>1<\/td>too few<\/td><\/tr>\r\n
Thymosin Alpha 1<\/a><\/td>1<\/td>0<\/td>0<\/td>1<\/td>too few<\/td><\/tr>\r\n
VIP<\/a><\/td>1<\/td>0<\/td>0<\/td>1<\/td>too few<\/td><\/tr>\r\n<\/tbody><\/table>
Pass rate = passed \/ (passed + failed) under Finnrick’s Purity Focus standard; tests with incomplete data are excluded. Overall pass rates are shown only for peptides with at least 70 tests. Click a peptide for its full record on Finnrick.<\/figcaption><\/figure>\r\n\r\n\r\n\r\n

Comment<\/h2>\r\n\r\n\r\n\r\n